Our findings highlight the significance of ubiquitin signalling as a variable contributing to AD pathology and present a nonclinical platform for testing potential therapeutics.
Kudos and Cheers to all the authors specifically Inbal, Mahasen and Anwar for their hard work, and dedication to this amazing achievement!